No photo of Peter Teismann

Peter Teismann


    • 94 Citations
    If you made any changes in Pure these will be visible here soon.

    Fingerprint Dive into the research topics where Peter Teismann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Medicine & Life Sciences
    Parkinson Disease Medicine & Life Sciences
    Glycyrrhizic Acid Medicine & Life Sciences
    Substantia Nigra Medicine & Life Sciences
    Pathology Medicine & Life Sciences
    Neutralizing Antibodies Medicine & Life Sciences
    Proteins Medicine & Life Sciences
    Cell Death Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 2000 2016

    • 94 Citations
    • 4 Article
    • 1 Poster
    25 Citations (Scopus)
    4 Downloads (Pure)

    In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin

    Santoro, M., Maetzler, W., Stathakos, P., Martin, H. L., Hobert, M. A., Rattray, T. W., Gasser, T., Forrester, J. V., Berg, D., Tracey, K. J., Riedel, G. & Teismann, P., Jul 2016, In : Neurobiology of Disease. 91, p. 59-68 10 p.

    Research output: Contribution to journalArticle

    Open Access
    Glycyrrhizic Acid
    Parkinson Disease
    Cell Death
    4 Citations (Scopus)
    4 Downloads (Pure)

    The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease

    Mustafa, S., Martin, H. L., Burkly, L., Costa, A., Martins, M. L., Schwaninger, M. & Teismann, P., 5 Apr 2016, In : Neuroscience. 319, p. 116-122 7 p.

    Research output: Contribution to journalArticle

    Open Access
    Parkinson Disease
    Substantia Nigra
    23 Citations (Scopus)
    4 Downloads (Pure)

    Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

    Mounsey, R. B., Mustafa, S., Robinson, L., Ross, R. A., Riedel, G., Pertwee, R. G. & Teismann, P., Nov 2015, In : Experimental Neurology. 273, p. 36-44 9 p.

    Research output: Contribution to journalArticle

    Open Access

    Pharmacological and genetic manipulation of peroxisome proliferator-activated receptors in the MPTP model of Parkinson’s disease

    Mounsey, R. B., Martin, H. L., Mustafa, S., Sathe, K., Nelson, M., Evans, R. M. & Teismann, P., 2013.

    Research output: Contribution to conferencePoster

    42 Citations (Scopus)
    Hydroxyl Radical
    Free Radicals
    Glutamic Acid